Literature DB >> 19570117

Resource use associated with type 2 diabetes in Asia, Latin America, the Middle East and Africa: results from the International Diabetes Management Practices Study (IDMPS).

A Ringborg1, C Cropet, B Jönsson, J J Gagliardino, A Ramachandran, P Lindgren.   

Abstract

AIMS: To estimate diabetes-related resource use and investigate its predictors among individuals with type 2 diabetes in 24 countries in Asia, Latin America, the Middle East and Africa.
METHODS: Cross-sectional observational data on diabetes-related resource use were collected from 15,016 individuals with type 2 diabetes within the second wave of International Diabetes Management Practices Study. Mean (SD) annual quantities were determined and predictors of diabetes-related hospitalisations, inpatient days, emergency room visits and absenteeism were investigated using negative binomial regression.
RESULTS: Patients in Asia (n = 4678), Latin America (n = 6090) and the Middle East and Africa (n = 4248) made a mean (SD) of 3.4 (6.9), 5.4 (6.7) and 2.5 (4.4) General Practitioner visits per year. The mean (SD) number of inpatient days amounted to 3.8 (18.1), 2.2 (13.9) and 2.6 (13.5) per year. Results of the regression analysis showed the major influence of diabetes-related complications and inadequate glycaemic control on resource use. The expected annual rate of hospitalisation of patients with macrovascular complications compared with those without was 4.7 times greater in Asia [incidence rate ratio (IRR) = 4.7, 95% CI: 2.8-7.8, n = 2551], 5.4 times greater in Latin America (IRR = 5.4, 95% CI: 3.0-9.8, n = 3228) and 4.4 times greater in the Middle East and Africa (IRR = 4.4, 95% CI: 2.8-6.9, n = 2630).
CONCLUSIONS: Micro- and macrovascular complications and inadequate glycaemic control are significant predictors of resource use in people with type 2 diabetes of developing countries. This knowledge confirms the health economic importance of early diagnosis of diabetes, education of patients and glycaemic control.

Entities:  

Mesh:

Year:  2009        PMID: 19570117     DOI: 10.1111/j.1742-1241.2009.02098.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  17 in total

1.  6(th) Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2015

2.  Management of diabetes in Morocco: results of the International Diabetes Management Practices Study (IDMPS) - wave 5.

Authors:  Asmae Chadli; Siham El Aziz; Nawal El Ansari; Farida Ajdi; Mehdi Seqat; Hanane Latrech; Ghizlaine Belmejdoub
Journal:  Ther Adv Endocrinol Metab       Date:  2016-04-13       Impact factor: 3.565

3.  One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS).

Authors:  Juliana C N Chan; Juan José Gagliardino; Hasan Ilkova; Fernando Lavalle; Ambady Ramachandran; Jean Claude Mbanya; Marina Shestakova; Cecile Dessapt-Baradez; Jean-Marc Chantelot; Pablo Aschner
Journal:  Adv Ther       Date:  2021-05-12       Impact factor: 3.845

4.  Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina.

Authors:  Jorge F Elgart; Joaquin E Caporale; Lorena Gonzalez; Eleonora Aiello; Maximiliano Waschbusch; Juan J Gagliardino
Journal:  Health Econ Rev       Date:  2013-04-27

5.  Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal.

Authors:  Sanjib Kumar Sharma; Anup Ghimire; Jeyasundar Radhakrishnan; Lekhjung Thapa; Nikesh Raj Shrestha; Navaraj Paudel; Keshar Gurung; Maskey R; Anjali Budathoki; Nirmal Baral; David Brodie
Journal:  Int J Hypertens       Date:  2011-04-19       Impact factor: 2.420

Review 6.  Challenges in diabetes management in Indonesia: a literature review.

Authors:  Pradana Soewondo; Alessandra Ferrario; Dicky Levenus Tahapary
Journal:  Global Health       Date:  2013-12-03       Impact factor: 4.185

7.  Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics.

Authors:  Paul Y Takahashi; Jennifer L St Sauver; Lila J Finney Rutten; Robert M Jacobson; Debra J Jacobson; Michaela E McGree; Jon O Ebbert
Journal:  Diabetes Metab Syndr Obes       Date:  2014-12-16       Impact factor: 3.168

8.  Health System Capacity and Access Barriers to Diagnosis and Treatment of CVD and Diabetes in Nepal.

Authors:  Abhishek Sharma; Warren A Kaplan; Gautam Satheesh; Indra Prasad Poudyal; Pawan Gyawali; Dinesh Neupane; Parash Mani Bhandari; Milan Malla; Surendra Sapkota; Shiva Raj Mishra
Journal:  Glob Heart       Date:  2021-05-18

Review 9.  Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.

Authors:  Joaquín E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Global Health       Date:  2013-10-29       Impact factor: 4.185

10.  Use of medical services and medicines attributable to diabetes in Sub-Saharan Africa.

Authors:  Jonathan Betz Brown; Kaushik Ramaiya; Stéphane Besançon; Paul Rheeder; Clarisse Mapa Tassou; Jean-Claude Mbanya; Katarzyna Kissimova-Skarbek; Eva Wangechi Njenga; Eva Wangui Muchemi; Harrison Kiambuthi Wanjiru; Erin Schneider
Journal:  PLoS One       Date:  2014-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.